1. | dartagnan4033 | |
2. | 1795josephb | |
3. | ttat5144 | |
4. | jenandchino | |
5. | fsuhines |
1. | dartagnan4033 | |
2. | 1795josephb | |
3. | ttat5144 | |
4. | jenandchino | |
5. | fsuhines |
1. | ttat5144 02/15/2018 ***$INCY NEWS*** |
2. | ttat5144 04/06/2018 Any idea how long |
3. | 1795josephb 04/06/2018 It'll be back up tomorrow. |
4. | dartagnan4033 04/06/2018 In again |
5. | dartagnan4033 04/06/2018 Incyte (INCY) Shares Remain Attractive, Says Top Analyst |
6. | 1795josephb 04/06/2018 What's in Store for Incyte Corporation (INCY) After "Big Time" Clinical Miss? Reni Benjamin Chimes In |
7. | 1795josephb 03/14/2018 Granted orphan drug designation by the FDA for Pemigatinib for the treatment of cholangiocarcinoma |
8. | dartagnan4033 02/15/2018 Beats EPS estimates by $0.46 and beats on revenues |
9. | dartagnan4033 04/19/2018 Shares indicated lower ahead on bearish outlook on Ad Com review for arthritis med baricitinib |